banner
Pseudoginsenoside RT1
Inquiry

Cat. No.: X22-05-ZQ208

Pseudoginsenoside RT1

Synonym: 98474-74-9; Pseudoginsenoside Rt1; (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-Heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxane-2-carboxylic acid

  • CAS Number: 98474-74-9
  • Compound CID: 21633069
img
Product Size
20 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Pseudoginsenoside RT1 is a triterpenoid saponin that exhibits acute ichthyotoxic activity. This product can be used for research in the field of agriculture and pharmaceuticals.
Molecular Weight
927.08
Molecular Formula
C47H74O18
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
Pseudoginsenoside RT1 can be used for research in the field of agriculture and pharmaceuticals.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0